A Fast Fish with a Huge Impact on Cancer and Metabolic Disease Therapeutics


Sung-Min Ahn, MD-PhD

Sung-Min is a founder and co-CEO of ImmunoForge. He is currently director of Gachon Institute of Genome Medicine and Science and an associate professor of Gachon University Gil Medical Center in Korea, working for Dept. of Genome Medicine and Science and for Dept. of Medical Oncology. Sung-Min has been serving as a member of scientific advisory board of WIN consortium, worldwide innovative networking in personalized cancer medicine. He is also a member of IBM’s innovation council for oncology data and evidence. Sung-Min received his BSc in Molecular Biology and Biochemistry from the University of Queensland. He received his M.D degree from Ajou University, and his PhD from the University of Melbourne with emphasis on genomics and proteomics.

Kiho Chang, MBA

Kiho is a founder and co-CEO/COO of ImmunoForge. He has more than 25 years’ of experience in the pharmaceutical field. Before joining ImmunoForge, Kiho worked for leading pharmaceutical companies in Korea such as Dong-A Pharma., LG Chem., and Ahn-Gook Pharma. His work experience spans from research, quality control, and manufacturing to business development. Serving as the head of biosimilar division in LG Chem., Kiho developed a new business model for the development of biopharmaceuticals; he conducted clinical studies simultaneously in Korea and Japan, successfully launching the pipelines. Kiho received his BSc in Biology from Seogang University, and MBA degree from Yonsei University.

Eunkyu Lee, PhD

Eunkyu is the CTO of ImmunoForge. He has affluent experience in academia, biotech industry, and the government sector. He worked for Hanyang University, and served as a vice president for Gachon University. He also served as head of basic and medical research division of the National Research Foundation leading grant allocation of ~1 billion USD per year. Eunkyu has more than 10 years of experience in the US biotech industry. He has been working as a senior advisor to a number of leading Korean biopharmaceutical companies. Eunkyu received BSc in Chemical Engineering from Hanyang University, and PhD in Biochemical Engineering from Drexel University.

Sukkyoon Yoon, PhD

Sukkyoon is the CSO of ImmunoForge. He worked for leading pharmaceutical companies in Korea such as Dong-A Pharma., LG Chem. From 2011 to 2017, Sukkyoon served as the head of New Drug Development Center of Daegu-Gyeongbuk Medical Innovation Foundation, a government organization. He received his BSc in Chemistry from Seogang University, and PhD from the University of Rochester. He worked for Harvard University as a postdoctoral researcher.


307-1, 105-1 Bldg, Seoul National Univ., 1 Gwanak-ro, Gwanak-gu, Seoul 08826, South-Korea


TEL: +82-70-7721-0755

FAX : +82-2-883-1662